Andrew Hider is the founder of Bardy Diagnostics. Bardy Diagnostics has raised $375M in total funding. Latest round: Series B. Based in New Providence, NJ.
Andrew Hider founded Bardy Diagnostics in 2013, a cardiac monitoring company later acquired by Hillrom in August 2021 for $375 million. As of August 2024, he became the President and CEO of Baxter International, where he received $29.8 million in total compensation for 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library